# Prevention of Benzodiazepine Misuse in Primary Care

> **NCT04533230** · NA · WITHDRAWN · sponsor: **Karolinska Institutet**

## Conditions studied

- Benzodiazepine Dependence
- Benzodiazepine Abuse
- Substance Use Disorders

## Interventions

- **BEHAVIORAL:** Educational intervention with prescription feedback
- **BEHAVIORAL:** Information on treatment guidelines

## Key facts

- **NCT ID:** NCT04533230
- **Lead sponsor:** Karolinska Institutet
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2020-09-01
- **Primary completion:** 2024-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** The study was stopped due to the COVID-19 pandemic restricting access to primary healthcare clinics.
- **Last updated:** 2023-02-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04533230

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04533230, "Prevention of Benzodiazepine Misuse in Primary Care". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04533230. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
